ilmscore | Prediction Details
"Skyrizi and Rinvoq both continue their Blockbuster growth expected to reach $27 billion in global sales by 2027 from just 16 billion this year."
By Let's Talk Money! with Joseph Hogue, CFA | April 10, 2024 | Pending
From video
7 Dividend Kings for a Bullet-Proof Portfolio in 2024 00:09:26 - 00:09:34
Interpreted Prediction
AbbVie's drugs Skyrizi and Rinvoq are expected to achieve $27 billion in global sales by 2027.

Prediction Details

Ticker
ABBV

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.